- /
- Supported exchanges
- / US
- / PMN.NASDAQ
ProMIS Neurosciences Inc. (PMN NASDAQ) stock market data APIs
ProMIS Neurosciences Inc. Financial Data Overview
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for the treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get ProMIS Neurosciences Inc. data using free add-ons & libraries
Get ProMIS Neurosciences Inc. Fundamental Data
ProMIS Neurosciences Inc. Fundamental data includes:
- Net Revenue: 7 558
- EBITDA: -13 306 319
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get ProMIS Neurosciences Inc. Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-04-06
- EPS/Forecast: -0.205
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ProMIS Neurosciences Inc. News
New
ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights
Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from long-term global investors. Proceeds are expected to fund the Company through...
3 European Dividend Stocks Yielding Up To 4.4%
As European markets experience a positive upswing, with the STOXX Europe 600 Index rising by 1.91% amid easing geopolitical tensions and steady corporate earnings, investors are increasingly looking t...
ProMIS Neurosciences GAAP EPS of -$22.61 misses by $2.57
* ProMIS Neurosciences press release [https://seekingalpha.com/pr/20450565-promis-neurosciences-announces-full-year-2025-financial-results-and-provides-corporate] (PMN [https://seekingalpha.com/symbo...
Five US Stocks See Over $185M in Insider Buying, with Soho House and WR Berkley Leading the Pack
Quick Read Soho House (SHCO) saw a $100M insider purchase as it completed its merger with MCR Hospitality Fund IV. W.R. Berkley attracted $57M in sustained insider buying despite quarterly earnings d...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.